GEN Share Price

Open 0.16 Change Price %
High 0.16 1 Day -0.01 -6.67
Low 0.14 1 Week -0.02 -12.50
Close 0.14 1 Month 0.00 0.00
Volume 639296 1 Year -0.02 -12.50
52 Week High 0.57
52 Week Low 0.12
GEN Important Levels
Resistance 2 0.16
Resistance 1 0.15
Pivot 0.15
Support 1 0.13
Support 2 0.12
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
TBE 0.03 0.00%
CVE 9.34 -2.51%
CVE 9.34 -2.51%
CVE 9.34 -2.51%
ECA 12.34 1.40%
More..
TSE Canada Top Gainers Stocks
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
TVI 0.02 100.00%
TLB 4.09 83.41%
TLB 4.09 83.41%
PWC 0.10 25.00%
PWC 0.10 25.00%
CUM 0.90 13.92%
CUM 0.90 13.92%
More..
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
MSV 1.01 -10.62%
CTU-A 0.19 -9.52%
MNR 0.20 -9.09%
MNR 0.20 -9.09%
HWO 3.83 -8.15%
CAS 16.22 -7.58%
CAS 16.22 -7.58%
CAS 16.22 -7.58%
CAS 16.22 -7.58%
More..

GeneNews Ltd. (TSE: GEN)

GEN Technical Analysis 5
As on 21st Jul 2017 GEN Share Price closed @ 0.14 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.32 & Strong Sell for SHORT-TERM with Stoploss of 0.20 we also expect STOCK to react on Following IMPORTANT LEVELS.
GEN Target for July
1st Target up-side 0.25
2nd Target up-side 0.29
3rd Target up-side 0.33
1st Target down-side 0.13
2nd Target down-side 0.09
3rd Target down-side 0.05
GEN Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.genenews.com
GEN Address
GEN
445 Apple Creek Boulevard
Suite 220
Markham, ON L3R 9X7
Canada
Phone: 905-739-2030
Fax: 905-739-2031
GEN Latest News
GeneNews Announces Extension of Warrant Exercise Incentive Program   MarketWatch   - 15th Jul 17
GeneNews Announces Issuance of Common Shares In Lieu Of Cash Payments to ...   Canada NewsWire (press release)   - 15th Jul 17
GeneNews Signs Binding Commitment Letter with Milost Global for US$10 Million ...   MarketWatch   - 30th Jun 17
$0.00 EPS Expected for GeneNews Ltd (GEN)   KL Daily   - 20th Jun 17
EPS for GeneNews Ltd (GEN) Expected At $0.00   KL Daily   - 02nd Jun 17
Director Decreases Ownership in GeneNews Limited   Canada NewsWire (press release)   - 03rd Jan 17
GeneNews Announces Closing of Private Placement of Convertible Debentures   Canada NewsWire (press release)   - 29th Dec 16
GeneNews Provides Financing Update   GlobeNewswire (press release)   - 27th Jul 16
GeneNews: The Market Leader In Colorectal Cancer Molecular Diagnostics   Seeking Alpha   - 05th Jul 13
0.16   MarketWatch   - 10th May 11
Interactive Technical Analysis Chart GeneNews Ltd. ( GEN TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on GeneNews Ltd.
GEN Business Profile
GeneNews Limited, a molecular diagnostics company, focuses on the development and application of functional genomics to enable early diagnosis and personalized health management based on disease specific biomarkers. Its principal platform technology, the Sentinel Principle, detects and stages various diseases or medical conditions from a blood sample. The company is applying the Sentinel Principle in the areas of cancer, arthritis, cardiovascular diseases, and neurological disorders. Its lead product includes ColonSentry, a blood-based molecular test to aid physicians in determining an individual’s risk of having colorectal cancer. The company was formerly known as ChondroGene Limited and changed its name to GeneNews Limited in October 2006. GeneNews Limited was founded in 1998 and is headquartered in Markham, Canada.